title: Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.
abstract: Type 2 diabetes carries a risk for hypoglycemia, particularly in patients on an intensive glucose control plan as a glucose-lowering strategy, where hypoglycemia may be a limitation for the therapy and also a factor underlying clinical inertia. Glucose-lowering medications that increase circulating insulin in a glucose-independent manner, such as insulin and sulfonylurea therapy, are the most common cause of hypoglycemia. However, other factors such as a delayed or missed meal, physical exercise, or drug or alcohol consumption may also contribute. Specific risk factors for development of hypoglycemia are old age, long duration of diabetes, some concomitant medication, renal dysfunction, hypoglycemia unawareness, and cognitive dysfunction. Hypoglycemia is associated with acute short-term symptoms related to either counterregulation, such as tachycardia and sweating, or to neuroglycopenia, such as irritability, confusion, and in severe cases stupor, coma, and even death. However, there are also long-term consequences of hypoglycemia such as reduced working capacity, weight gain, loss of self-confidence with reduced quality of life, and increased risk for cardiovascular diseases. For both the patients, the health care system, and the society at large, hypoglycemia carries a high cost. Strategies to mitigate the risk of hypoglycemia include awareness of the condition; education of patients, relatives, and health care providers; and selecting appropriate glucose-lowering medication that also judges the risk for hypoglycemia to prevent this complication. This article summarizes the current knowledge of hypoglycemia and its consequences with a special emphasis on its consequences for the choice of glucose-lowering therapy.
authors: Department of Clinical Sciences, Lund, Faculty of Medicine, Lund University, Lund, Sweden. bo.ahren@med.lu.se
authors: Bo
authors: B
authors: Ahrén
mesh_terms: D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D017048:Health Care Costs; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000191:economics; D015994:Incidence; D010353:Patient Education as Topic; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D007004:Hypoglycemic Agents
keywords: hypoglycemia; incretin therapy; insulin; sulfonylurea; treatment; type 2 diabetes
references: Diabet Med. 2005 Jun;22(6):749-55
references: 15910627
references: J Intern Med. 1999 Sep;246(3):299-307
references: 10475998
references: Diabetologia. 2002 Jul;45(7):937-48
references: 12136392
references: Diabetes Care. 2009 Sep;32(9):1649-55
references: 19478198
references: Diabetes Obes Metab. 2011 Jan;13(1):65-74
references: 21114605
references: Int J Clin Pract. 2011 Mar;65(3):314-22
references: 21314869
references: Best Pract Res Clin Endocrinol Metab. 2007 Dec;21(4):517-33
references: 18054733
references: Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S53-64
references: 21668338
references: Diabetes Care. 2004 Oct;27(10):2306-11
references: 15451892
references: Drugs. 2004;64(12):1339-58
references: 15200348
references: Diabetes Metab Res Rev. 2008 Feb;24(2):87-92
references: 18088077
references: Int J Clin Pract. 2009 Jan;63(1):46-55
references: 19125992
references: J Am Med Dir Assoc. 2012 Mar;13(3):234-8
references: 21450199
references: J Diabetes Complications. 2006 Nov-Dec;20(6):395-401
references: 17070446
references: Diabetes Care. 2003 Apr;26(4):1153-7
references: 12663589
references: Diabetes Res Clin Pract. 2010 Aug;89(2):126-33
references: 20541825
references: N Engl J Med. 2010 Oct 7;363(15):1410-8
references: 20925543
references: Diabetes Metab. 2010 Oct;36 Suppl 3:S75-83
references: 21211740
references: Diabetes Care. 2003 Apr;26(4):1176-80
references: 12663593
references: Diabetes Care. 2006 Dec;29(12):2638-43
references: 17130197
references: Diabetes Care. 2005 Dec;28(12):2948-61
references: 16306561
references: Diabetes Metab. 2010 Oct;36 Suppl 3:S106-11
references: 21211731
references: Diabetes Care. 2009 Jan;32(1):193-203
references: 18945920
references: Diabetes Res Clin Pract. 2011 Sep;93(3):328-36
references: 21640424
references: Diabet Med. 2003 Dec;20(12):1016-21
references: 14632703
references: J Clin Endocrinol Metab. 1997 Feb;82(2):473-8
references: 9024239
references: Diabetologia. 2010 Aug;53(8):1552-61
references: 20407743
references: Int J Clin Pract. 2010 Jul;64(8):1121-9
references: 20236369
references: Endocrinology. 2012 Mar;153(3):1055-62
references: 22315452
references: N Engl J Med. 2006 Dec 7;355(23):2427-43
references: 17145742
references: J Clin Endocrinol Metab. 1997 May;82(5):1458-61
references: 9141533
references: Diabet Med. 1999 Jul;16(7):586-90
references: 10445835
references: Horm Metab Res Suppl. 1985;15:105-11
references: 3935560
references: Health Qual Life Outcomes. 2008 Oct 31;6:88
references: 18976457
references: Diabetes Care. 2012 Jul;35(7):1446-54
references: 22584132
references: J Clin Endocrinol Metab. 1999 Sep;84(9):3140-5
references: 10487677
references: Diabetes Care. 2007 Apr;30(4):890-5
references: 17277036
references: Expert Opin Drug Saf. 2010 Sep;9(5):675-81
references: 20553106
references: Diabetes Nutr Metab. 2004 Feb;17(1):23-6
references: 15163121
references: Am J Manag Care. 2011 Oct;17(10):673-80
references: 22106460
references: Diabetes Care. 2005 Apr;28(4):950-5
references: 15793205
references: Diabetes Care. 2012 May;35(5):1126-32
references: 22432106
references: Value Health. 2011 Jul-Aug;14(5):665-71
references: 21839404
references: Diabetes Care. 2009 Jan;32(1):84-90
references: 18931095
references: Curr Med Res Opin. 2006 Aug;22(8):1523-34
references: 16870077
references: Diabet Med. 2012 Mar;29(3):293-302
references: 21838763
references: Curr Med Res Opin. 2012 Apr;28(4):513-23
references: 22313154
references: Diabetes. 2004 Sep;53(9):2397-403
references: 15331551
references: Diabetologia. 2007 Jun;50(6):1140-7
references: 17415551
references: Nat Rev Endocrinol. 2012 Dec;8(12):728-42
references: 22945360
references: Endocrinology. 2012 Mar;153(3):1039-48
references: 22166985
references: Diabetes Care. 2005 May;28(5):1092-100
references: 15855572
references: Diabet Med. 2008 Mar;25(3):245-54
references: 18215172
references: Diabetes Obes Metab. 2012 Dec;14(12):1081-7
references: 22726104
references: Clin Ther. 2007 Jun;29(6):987-99
references: 17692716
references: Diabetologia. 2006 Mar;49(3):434-41
references: 16477438
references: Diabetologia. 2007 Jun;50(6):1148-55
references: 17387446
references: J Clin Endocrinol Metab. 2009 Apr;94(4):1236-43
references: 19174497
references: N Engl J Med. 2011 Nov 24;365(21):2002-12
references: 22111719
references: Exp Cell Res. 2011 May 15;317(9):1239-45
references: 21237153
references: Value Health. 2006 May-Jun;9(3):193-8
references: 16689714
references: Diabetes Care. 2005 May;28(5):1245-9
references: 15855602
references: Diabetes Metab. 1998 Sep;24(4):311-20
references: 9805641
references: Diabetes Care. 2012 Apr;35(4):787-93
references: 22374637
references: Diabetes Obes Metab. 2010 Feb;12(2):167-77
references: 20092585
references: N Engl J Med. 2008 Oct 9;359(15):1577-89
references: 18784090
references: Diabetologia. 2009 Nov;52(11):2288-98
references: 19655124
references: Arch Intern Med. 2001 Jul 9;161(13):1653-9
references: 11434798
references: Acta Biomed. 2008 Dec;79(3):184-91
references: 19260377
references: Diabetes Care. 2010 Jun;33(6):1389-94
references: 20508232
references: Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S92-6
references: 21864759
references: Diabetes Obes Metab. 2012 Jan;14 Suppl 1:9-13
references: 22118705